Brovana

Drug Details

Arformoterol, marketed as Brovana, is a long-term treatment designed to aid individuals with chronic obstructive pulmonary disease (COPD), including conditions like chronic bronchitis and emphysema, in managing their symptoms such as wheezing and shortness of breath. Classified as a long-acting beta agonist (LABA) and a bronchodilator, Arformoterol functions by relaxing the muscles around the airways, enabling them to open, which facilitates easier breathing. Administered through a nebulizer twice daily, this medication significantly improves lung function and reduces the likelihood of hospitalization due to worsening COPD symptoms. It is important to note that Arformoterol is not intended for immediate relief of sudden breathing difficulties and should not be used for asthma management. A quick-relief inhaler, like albuterol, should be kept on hand for sudden shortness of breath. Consult with your healthcare provider to ensure a comprehensive treatment plan, as using LABAs like Arformoterol without an inhaled corticosteroid can increase the risk of severe respiratory issues in asthma patients. Always follow your healthcare provider's instructions regarding medication use.